SPIRA Anterior Lumbar Spacers ↗
Anterior lumbar interbody implants. [33][2]
FDA-clearedCommercially offered; exact model and country availability should be confirmed with the manufacturer.

Spinal implants and instrumentation, including porous SPIRA interbody devices and minimally invasive fixation.
Camber Spine develops implants and instrumentation for spinal surgery. Its SPIRA portfolio uses open implant structures intended to support fusion procedures, while ENZA addresses fixation through minimally invasive approaches.
Selected FDA records cover SPIRA Anterior Lumbar Spacers and the SPIRA-C Integrated Fixation System. Each clearance relates to its named product and indications.
Founding partner Seth Anderson serves as CEO, with Daniel Pontecorvo as executive chair and Chad Spear leading U.S. sales. The company’s commercial story centers on surgeon engagement, implant engineering and procedural instrumentation across spinal fusion workflows.
Camber’s SPIRA and ENZA spine families have multiple distinct 510(k) decisions, including earlier family clearances missing from the previous snapshot. The wider FDA record also contains fixation, navigation and other interbody systems; these records do not mean every historical model is part of the selected commercial snapshot. [33][30][31][32][4][34]
No matching FDA recall event was identified in the completed company/applicant, linked-identifier and product-name searches. [36][37]
Latest recorded source review: 2026-10-20.
Documented commercial product families.
Anterior lumbar interbody implants. [33][2]
FDA-clearedCommercially offered; exact model and country availability should be confirmed with the manufacturer.
Cervical interbody implant with integrated fixation. [33][3]
FDA-clearedCommercially offered; exact model and country availability should be confirmed with the manufacturer.
Minimally invasive fixation product family. [33]
Marketed · regulatory scope variesCommercially offered; exact model and country availability should be confirmed with the manufacturer.
Accessed 10/20/2026